Increased Risk of Acute Myocardial Infarction in Systemic Sclerosis: A Nationwide Population-based Study

被引：64

作者：

Chu, Szu-Ying ^{[1
,2
,3
]}

Chen, Yi-Ju ^{[2
,4
]}

Liu, Chia-Jen ^{[5
,6
,7
,8
]}

Tseng, Wei-Cheng ^{[6
,9
]}

Lin, Ming-Wei ^{[5
]}

Hwang, Chian-Yaw ^{[1
,2
]}

Chen, Chih-Chiang ^{[1
,2
]}

Lee, Ding-Dar ^{[1
,2
]}

Chen, Tzeng-Ji ^{[10
]}

Chang, Yun-Ting ^{[1
,2
]}

Wang, Wen-Jen ^{[1
,2
]}

Liu, Han-Nan ^{[1
,2
,11
]}

机构：

[1] Taipei Vet Gen Hosp, Dept Dermatol, Taipei 112, Taiwan

[2] Natl Yang Ming Univ, Dept Dermatol, Taipei 112, Taiwan

[3] Natl Yang Ming Univ, Inst Clin Med, Taipei 112, Taiwan

[4] Taichung Vet Gen Hosp, Dept Dermatol, Taichung, Taiwan

[5] Natl Yang Ming Univ, Inst Publ Hlth, Taipei 112, Taiwan

[6] Natl Yang Ming Univ, Sch Med, Taipei 112, Taiwan

[7] Taipei Vet Gen Hosp, Dept Med, Div Hematol & Oncol, Taipei, Taiwan

[8] Natl Yang Ming Univ Hosp, Dept Internal Med, Yilan, Taiwan

[9] Taipei City Hosp, Dept Med, Heping Fuyou Branch, Taipei, Taiwan

[10] Taipei Vet Gen Hosp, Dept Family Med, Taipei, Taiwan

[11] Natl Def Med Ctr, Dept Dermatol, Taipei, Taiwan

来源：

AMERICAN JOURNAL OF MEDICINE | 2013年 / 126卷 / 11期

关键词：

Cardiovascular risk; Coronary artery disease; Immunosuppressor; Myocardial infarction; Systemic sclerosis; INSURANCE RESEARCH DATABASE; INVOLVEMENT; DIAGNOSIS; FIBROSIS; DISEASE; EXPERIENCE; TAIWAN; COHORT;

D O I：

10.1016/j.amjmed.2013.06.025

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

PURPOSE: Systemic sclerosis is a life-threatening autoimmune disease characterized by vasculopathy, which results in myocardial involvement in an extremely high percentage of patients. Nevertheless, there have been no large-scale epidemiological studies about the risk of acute myocardial infarction in patients with systemic sclerosis. The aims of this study were to evaluate the hazard ratio (HR) and risk factors of acute myocardial infarction in patients with systemic sclerosis, as well as to compare the risks of acute myocardial infarction among systemic sclerosis patients taking different immunosuppressors. METHODS: The study cohort included 1344 patients with systemic sclerosis and 13,440 (1: 10) age-, sex-, and comorbidity-matched controls during the period between 1997 and 2006, from the National Health Insurance Research Database. We compared the risk of acute myocardial infarction between patients with systemic sclerosis and controls and calculated the adjusted HRs for acute myocardial infarction in systemic sclerosis patients taking immunosuppressors and not taking immunosuppressors. RESULTS: The incidence rates of acute myocardial infarction were 535 and 313 cases per 100,000 person-years for systemic sclerosis cohort and reference cohort, respectively (P <.001, unadjusted). After adjusting for age, sex, and underlying medical diseases on Cox proportional hazards model, systemic sclerosis was found to be an independent risk factor for acute myocardial infarction (HR 2.45). Other risk factors included hypertension (HR 2.08) and diabetes (HR 2.14). The multivariate adjusted HR for acute myocardial infarction did not decrease among the systemic sclerosis patients taking systemic steroids, penicillamine, cyclophosphamide, azathioprine, methotrexate, or cyclosporine. CONCLUSION: Systemic sclerosis is independently associated with an increased risk of acute myocardial infarction. Immunosuppressors do not lower the risk of acute myocardial infarction in our study. (C) 2013 Elsevier Inc. All rights reserved.

引用

页码：982 / 988

页数：7

共 39 条

[1]

Allanore Y, 2010, CLIN EXP RHEUMATOL, V28, pS48

[2] Prevalence and factors associated with left ventricular dysfunction in the EULAR Scleroderma Trial and Research group (EUSTAR) database of patients with systemic sclerosis [J].